发明名称 INHIBITION OF TUMOR ANGIOGENESIS BY CHECKPOINT INHIBITORS AND ACTIVE VACCINATION
摘要 Disclosed are compositions of matter, methods, and protocols useful for treatment of cancer through induction of anti-angiogenic immune responses by vaccination together with immune modulation triggered by checkpoint inhibitors. The invention provides placenta, placental endothelial, placental fibroblasts, and mixtures thereof as immunogens, whose anti-angiogenic activity is augmented by utilization of checkpoint inhibitors. Means of differentiating tumor cells directly into endothelial or endothelial-like cells and utilizing said cells as immunogens for the purpose of inducing immunity against blood vessels feeding tumors. In one embodiment CTLA4 blockade is performed in combination with an immunogen capable of triggering immunity towards tumor endothelial cells. In another embodiment blockade of the PD1-PD1 ligand pathway is performed in combination with induction of anti-angiogenic immune response.
申请公布号 US2017095545(A1) 申请公布日期 2017.04.06
申请号 US201615149130 申请日期 2016.05.07
申请人 Batu Biologics, Inc. 发明人 Wagner Samuel C.;Ichim Thomas E.;Bogin Vladimir
分类号 A61K39/00;A61K45/06 主分类号 A61K39/00
代理机构 代理人
主权项 1. A method of inducing tumor regression comprising the steps of: a) administering an immunogen capable of stimulating an immune response with selectivity to tumor associated endothelium; b) administering a checkpoint inhibitor.
地址 San Diego CA US